Cardiology Medical News about Cardiomyopathy, Hypertrophic

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death

3. The Job Market for 2008-2009: Compensation

4. Renal Artery Stenosis

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Severe Left Ventricular Wall Thinning and Extensive Fibrosis Without Evolution to End Stage Disease in a Patient With Hypertrophic Cardiomyopathy
Journal of The American Society of Echocardiography, 10/12/09

Assenza GE et al. – The authors report the case of a patient with hypertrophic cardiomyopathy who developed progressive and severe left ventricular wall thinning, as assessed by two–dimensional echocardiography, despite a preserved supranormal ejection fraction and an absence of cardiac symptoms. Extensive fibrosis was identified on cardiovascular magnetic resonance.

<< Previous
CYP3A5 polymorphism and sensitivity of blood pressure to dietary...

Next >>
Personalized medicine: Factors influencing reimbursement

Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy
European Heart Journal, 11/10/09 Relevance Score: 68%

Cell Cycle Re-Entry and Mitochondrial Defects in Myc-Mediated Hypertrophic Cardiomyopathy and Heart Failure
PLoS ONE - Cardiovascular Disorders, 10/02/09 Relevance Score: 67%

Severe Hypertrophic Cardiomyopathy in an Infant with a Novel PRKAG2 Gene Mutation: Potential Differences Between Infantile and Adult Onset Presentation
Pediatric Cardiology, 10/02/09 Relevance Score: 67%

Diagnostic accuracy of extended-length electrocardiogram in differentiating between athlete's heart and hypertrophic cardiomyopathy
Journal of Electrocardiology, 10/29/09 Relevance Score: 66%

Effect of agalsidase alfa replacement therapy on fabry disease—related hypertrophic cardiomyopathy: A 12- to 36-month, retrospective, blinded echocardiographic pooled analysis
Clinical Therapeutics, 10/29/09 Relevance Score: 66%